VWO vs IEMG: returns, risk and drawdowns compared
Vanguard FTSE Emerging Markets ETF against iShares Core MSCI Emerging Markets ETF, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
VWO
Vanguard FTSE Emerging Markets ETF
10,000 became
17,693
- A year on average
- +9.4%
- Annual volatility
- 14.4%
- Deepest fall
- −31.9%
- Worst month
- −10.1%
IEMG
iShares Core MSCI Emerging Markets ETF
10,000 became
19,160
- A year on average
- +10.8%
- Annual volatility
- 16.7%
- Deepest fall
- −34.6%
- Worst month
- −11.3%
IEMG came out ahead by 1.4 percentage points a year from July 2020 to October 2026. IEMG swung more (16.7% against 14.4% a year). The correlation of monthly returns was 0.97: they moved almost in lockstep.
Growth of 10,000: VWO vs IEMG
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero VWO had returned more, below zero IEMG. VWO was ahead in 59% of the 41 three-year periods.
Annualised 3-year return of VWO minus that of IEMG, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: VWO −31.9%, IEMG −34.6%.
All the figures
| VWO | IEMG | |
|---|---|---|
| Annual return (CAGR) | +9.4% | +10.8% |
| Total return | +77% | +92% |
| Annual volatility | 14.4% | 16.7% |
| Deepest fall (month-end) | −31.9% | −34.6% |
| Worst month | −10.1% | −11.3% |
| Best month | +14.3% | +14.7% |
| Positive months | 59% | 61% |
| Best year | 2025: +25.6% | 2025: +32.6% |
| Worst year | 2022: −18.0% | 2022: −20.0% |
| 1-year return | +8.8% | +17.0% |
| 5 years, a year | +5.3% | +6.8% |
| 10 years, a year | — | +8.3% |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half VWO, half IEMG
| VWO alone | IEMG alone | 50/50 | |
|---|---|---|---|
| A year on average | +9.4% | +10.8% | +10.1% |
| Annual volatility | 14.4% | 16.7% | 15.4% |
| Deepest fall (month-end) | −31.9% | −34.6% | −33.2% |
| Worst month | −10.1% | −11.3% | −10.7% |
With a correlation of 0.97 the mix behaved almost like either fund alone: its volatility of 15.4% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, VWO or IEMG?
From July 2020 to October 2026, VWO returned +9.4% a year and IEMG +10.8% a year, with dividends reinvested. Over rolling 3-year periods VWO did better in 59% of cases. Past returns do not predict future returns.
Which is riskier, VWO or IEMG?
Over the same months annual volatility was 14.4% for VWO and 16.7% for IEMG; the deepest fall from a month-end high was 31.9% and 34.6%, and the worst single month −10.1% and −11.3%.
How correlated are VWO and IEMG?
The correlation of their monthly returns was 0.97: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both VWO and IEMG?
Half in each, rebalanced every month, returned +10.1% a year over the same period, with 15.4% annual volatility and a deepest month-end fall of 33.2%.
More comparisons
- VWO — Vanguard FTSE Emerging Markets ETFReturns, drawdowns and risk
- IEMG — iShares Core MSCI Emerging Markets ETFReturns, drawdowns and risk
- VWO vs EIMI
- VWO vs EEM
- VEA vs VWO
- IEMG vs EIMI
- IEMG vs EEM
- Backtest a portfolio on past crisesRebalancing, costs and attribution
- Portfolio stress testing software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.